80 related articles for article (PubMed ID: 21114600)
1. Glucagon-like peptide-1(9-36)amide metabolite inhibits weight gain and attenuates diabetes and hepatic steatosis in diet-induced obese mice.
Tomas E; Wood JA; Stanojevic V; Habener JF
Diabetes Obes Metab; 2011 Jan; 13(1):26-33. PubMed ID: 21114600
[TBL] [Abstract][Full Text] [Related]
2. GLP-1-derived nonapeptide GLP-1(28-36)amide inhibits weight gain and attenuates diabetes and hepatic steatosis in diet-induced obese mice.
Tomas E; Wood JA; Stanojevic V; Habener JF
Regul Pept; 2011 Aug; 169(1-3):43-8. PubMed ID: 21549160
[TBL] [Abstract][Full Text] [Related]
3. GLP-1-derived nonapeptide GLP-1(28-36)amide targets to mitochondria and suppresses glucose production and oxidative stress in isolated mouse hepatocytes.
Tomas E; Stanojevic V; Habener JF
Regul Pept; 2011 Apr; 167(2-3):177-84. PubMed ID: 21256872
[TBL] [Abstract][Full Text] [Related]
4. GLP-1 (9-36) amide metabolite suppression of glucose production in isolated mouse hepatocytes.
Tomas E; Stanojevic V; Habener JF
Horm Metab Res; 2010 Aug; 42(9):657-62. PubMed ID: 20645222
[TBL] [Abstract][Full Text] [Related]
5. Dietary modulation of clostridial cluster XIVa gut bacteria (Roseburia spp.) by chitin-glucan fiber improves host metabolic alterations induced by high-fat diet in mice.
Neyrinck AM; Possemiers S; Verstraete W; De Backer F; Cani PD; Delzenne NM
J Nutr Biochem; 2012 Jan; 23(1):51-9. PubMed ID: 21411304
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological targeting of glucagon and glucagon-like peptide 1 receptors has different effects on energy state and glucose homeostasis in diet-induced obese mice.
Gu W; Lloyd DJ; Chinookswong N; Komorowski R; Sivits G; Graham M; Winters KA; Yan H; Boros LG; Lindberg RA; Véniant MM
J Pharmacol Exp Ther; 2011 Jul; 338(1):70-81. PubMed ID: 21471191
[TBL] [Abstract][Full Text] [Related]
7. Glucagon-like peptide-2 receptor modulates islet adaptation to metabolic stress in the ob/ob mouse.
Bahrami J; Longuet C; Baggio LL; Li K; Drucker DJ
Gastroenterology; 2010 Sep; 139(3):857-68. PubMed ID: 20546737
[TBL] [Abstract][Full Text] [Related]
8. GLP-1(32-36)amide Pentapeptide Increases Basal Energy Expenditure and Inhibits Weight Gain in Obese Mice.
Tomas E; Stanojevic V; McManus K; Khatri A; Everill P; Bachovchin WW; Habener JF
Diabetes; 2015 Jul; 64(7):2409-19. PubMed ID: 25858562
[TBL] [Abstract][Full Text] [Related]
9. Co-agonist of glucagon and GLP-1 reduces cholesterol and improves insulin sensitivity independent of its effect on appetite and body weight in diet-induced obese C57 mice.
Patel V; Joharapurkar A; Dhanesha N; Kshirsagar S; Patel K; Bahekar R; Shah G; Jain M
Can J Physiol Pharmacol; 2013 Dec; 91(12):1009-15. PubMed ID: 24289070
[TBL] [Abstract][Full Text] [Related]
10. A novel human-based receptor antagonist of sustained action reveals body weight control by endogenous GLP-1.
Patterson JT; Ottaway N; Gelfanov VM; Smiley DL; Perez-Tilve D; Pfluger PT; Tschöp MH; Dimarchi RD
ACS Chem Biol; 2011 Feb; 6(2):135-45. PubMed ID: 20939591
[TBL] [Abstract][Full Text] [Related]
11. Glucagon-like peptide-1 receptor agonism improves metabolic, biochemical, and histopathological indices of nonalcoholic steatohepatitis in mice.
Trevaskis JL; Griffin PS; Wittmer C; Neuschwander-Tetri BA; Brunt EM; Dolman CS; Erickson MR; Napora J; Parkes DG; Roth JD
Am J Physiol Gastrointest Liver Physiol; 2012 Apr; 302(8):G762-72. PubMed ID: 22268099
[TBL] [Abstract][Full Text] [Related]
12. GLP-1-derived nonapeptide GLP-1(28-36)amide represses hepatic gluconeogenic gene expression and improves pyruvate tolerance in high-fat diet-fed mice.
Ip W; Shao W; Chiang YT; Jin T
Am J Physiol Endocrinol Metab; 2013 Dec; 305(11):E1348-58. PubMed ID: 24085036
[TBL] [Abstract][Full Text] [Related]
13. Exendin-4, a glucagon-like protein-1 (GLP-1) receptor agonist, reverses hepatic steatosis in ob/ob mice.
Ding X; Saxena NK; Lin S; Gupta NA; Anania FA
Hepatology; 2006 Jan; 43(1):173-81. PubMed ID: 16374859
[TBL] [Abstract][Full Text] [Related]
14. A novel aminosterol reverses diabetes and fatty liver disease in obese mice.
Takahashi N; Qi Y; Patel HR; Ahima RS
J Hepatol; 2004 Sep; 41(3):391-8. PubMed ID: 15336441
[TBL] [Abstract][Full Text] [Related]
15. Low-carbohydrate diet disrupts the association between insulin resistance and weight gain.
Leite JO; DeOgburn R; Ratliff JC; Su R; Volek JS; McGrane MM; Dardik A; Fernandez ML
Metabolism; 2009 Aug; 58(8):1116-22. PubMed ID: 19439329
[TBL] [Abstract][Full Text] [Related]
16. S 23521 decreases food intake and body weight gain in diet-induced obese rats.
Claret M; Corominola H; Canals I; Nadal B; Chavanieu A; Pfeiffer B; Renard P; Gorostiaga C; Delagrange P; Grassy G; Gomis R
Obes Res; 2004 Oct; 12(10):1596-603. PubMed ID: 15536223
[TBL] [Abstract][Full Text] [Related]
17. Glucagon-like peptide-1 gene therapy in obese diabetic mice results in long-term cure of diabetes by improving insulin sensitivity and reducing hepatic gluconeogenesis.
Lee YS; Shin S; Shigihara T; Hahm E; Liu MJ; Han J; Yoon JW; Jun HS
Diabetes; 2007 Jun; 56(6):1671-9. PubMed ID: 17369525
[TBL] [Abstract][Full Text] [Related]
18. Resistance to high-fat diet in the female progeny of obese mice fed a control diet during the periconceptual, gestation, and lactation periods.
Gallou-Kabani C; Vigé A; Gross MS; Boileau C; Rabes JP; Fruchart-Najib J; Jais JP; Junien C
Am J Physiol Endocrinol Metab; 2007 Apr; 292(4):E1095-100. PubMed ID: 17164437
[TBL] [Abstract][Full Text] [Related]
19. Oligofructose promotes satiety in rats fed a high-fat diet: involvement of glucagon-like Peptide-1.
Cani PD; Neyrinck AM; Maton N; Delzenne NM
Obes Res; 2005 Jun; 13(6):1000-7. PubMed ID: 15976142
[TBL] [Abstract][Full Text] [Related]
20. Diets containing Sophora japonica L. prevent weight gain in high-fat diet-induced obese mice.
Park KW; Lee JE; Park KM
Nutr Res; 2009 Nov; 29(11):819-24. PubMed ID: 19932871
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
